NASDAQ
MSAC

Medicus Sciences Acquisition Corp

Investment Holding Companies
Financials

Prices are adjusted according to historical splits.

Medicus Sciences Acquisition Corp Stock Price

Vitals

Today's Low:
$10.17
Today's High:
$10.17
Open Price:
$10.17
52W Low:
$9.875
52W High:
$10.18
Prev. Close:
$10.17
Volume:
0

Company Statistics

Market Cap.:
$118.12 million
Book Value:
-0.243
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-0.82%
Return on Equity TTM:
0%

Company Profile

Medicus Sciences Acquisition Corp had its IPO on 2021-04-07 under the ticker symbol MSAC.

The company operates in the Financials sector and Investment Holding Companies industry. Medicus Sciences Acquisition Corp has a staff strength of 0 employees.

Stock update

Shares of Medicus Sciences Acquisition Corp opened at $10.17 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $10.17 - $10.17, and closed at $10.17.

This is a -4.82% slip from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Medicus Sciences Acquisition Corp have slipped by -5.11%.

Medicus Sciences Acquisition Corp's Key Ratios

Medicus Sciences Acquisition Corp has a market cap of $118.12 million, indicating a price to book ratio of 1.2972 and a price to sales ratio of 0.

In the last 12-months Medicus Sciences Acquisition Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Medicus Sciences Acquisition Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Medicus Sciences Acquisition Corp’s operating margin was 0% while its return on assets stood at -0.82% with a return of equity of 0%.

In Q3, Medicus Sciences Acquisition Corp’s quarterly earnings growth was a negative -83.1% while revenue growth was a positive 0%.

Medicus Sciences Acquisition Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
31.7813
PEG

Its diluted EPS in the last 12-months stands at $0.32 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medicus Sciences Acquisition Corp’s profitability.

Medicus Sciences Acquisition Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -165.4304. Its price to sales ratio in the trailing 12-months stood at 0.

Medicus Sciences Acquisition Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$93.43 million
Total Liabilities
$55407.00
Operating Cash Flow
$0
Capital Expenditure
$0
Dividend Payout Ratio
0%

Medicus Sciences Acquisition Corp ended 2024 with $93.43 million in total assets and $0 in total liabilities. Its intangible assets were valued at $93.43 million while shareholder equity stood at $-2824511.00.

Medicus Sciences Acquisition Corp ended 2024 with $1.36 million in deferred long-term liabilities, $55407.00 in other current liabilities, 241.00 in common stock, $-2824752.00 in retained earnings and $0 in goodwill. Its cash balance stood at $976557.00 and cash and short-term investments were $976557.00. The company’s total short-term debt was $0 while long-term debt stood at $0.

Medicus Sciences Acquisition Corp’s total current assets stands at $1.05 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $118.00 compared to accounts payable of $55407.00 and inventory worth $0.

In 2024, Medicus Sciences Acquisition Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Medicus Sciences Acquisition Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$10.17
52-Week High
$10.18
52-Week Low
$9.875
Analyst Target Price
$

Medicus Sciences Acquisition Corp stock is currently trading at $10.17 per share. It touched a 52-week high of $10.18 and a 52-week low of $10.18. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $9.5 and 200-day moving average was $9.78 The short ratio stood at 0.11 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 12698.5% are held by institutions.

Frequently Asked Questions About Medicus Sciences Acquisition Corp

The stock symbol (also called stock or share ticker) of Medicus Sciences Acquisition Corp is MSAC

The IPO of Medicus Sciences Acquisition Corp took place on 2021-04-07

Similar Industry Stocks (Investment Holding Companies)

Last Price
Chg
Chg%
$38.22
-1.76
-4.4%
$37.7
0.73
+1.97%
$0.06
0.01
+11.32%
$142
-6.9
-4.63%
$15.82
-0.36
-2.23%
Eyenovia Inc (EYEN)
$1.83
0
0%
ATLXD (ATLXD)
$16.7
-0.04
-0.24%
$335.05
-5.8
-1.7%
$12.83
0.14
+1.1%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.

Address

152 West 57th Street, New York, NY, United States, 10019